These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1122 related articles for article (PubMed ID: 16942566)
21. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [TBL] [Abstract][Full Text] [Related]
22. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
23. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073 [TBL] [Abstract][Full Text] [Related]
24. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897 [TBL] [Abstract][Full Text] [Related]
25. The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects. Domdey A; Liu A; Millner A; Lund K; Jacobi H; Malling HJ; Søndergaard I; Würtzen PA Int Arch Allergy Immunol; 2010; 152(3):243-54. PubMed ID: 20150742 [TBL] [Abstract][Full Text] [Related]
26. Serum transforming growth factor-beta levels depend on allergen exposure in allergic rhinitis. Ciprandi G; De Amici M; Tosca M; Marseglia G Int Arch Allergy Immunol; 2010; 152(1):66-70. PubMed ID: 19940507 [TBL] [Abstract][Full Text] [Related]
27. Differential mRNA expression and production of interleukin-4 and interferon-gamma in stimulated peripheral blood mononuclear cells of house-dust mite-allergic patients. Laan MP; Baert MR; Vredendaal AE; Savelkoul HF Eur Cytokine Netw; 1998 Mar; 9(1):75-84. PubMed ID: 9613681 [TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165 [TBL] [Abstract][Full Text] [Related]
29. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis. Shida M; Kadoya M; Park SJ; Nishifuji K; Momoi Y; Iwasaki T Vet Immunol Immunopathol; 2004 Nov; 102(1-2):19-31. PubMed ID: 15451612 [TBL] [Abstract][Full Text] [Related]
30. [The imbalance of Th1/Th2 cytokine expression in peripheral blood mononuclear cell from asthmatic patients and the effect of erythromycin on these cytokines]. Xiao W; Yu H; Zheng C Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):347-50. PubMed ID: 11778516 [TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study. Höiby AS; Strand V; Robinson DS; Sager A; Rak S Clin Exp Allergy; 2010 Jul; 40(7):1062-70. PubMed ID: 20642579 [TBL] [Abstract][Full Text] [Related]
32. TGF-beta and IL-17 serum levels and specific immunotherapy. Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397 [TBL] [Abstract][Full Text] [Related]
33. The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice. Winkler B; Hufnagl K; Spittler A; Ploder M; Kállay E; Vrtala S; Valenta R; Kundi M; Renz H; Wiedermann U Allergy; 2006 Feb; 61(2):173-80. PubMed ID: 16409192 [TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188 [TBL] [Abstract][Full Text] [Related]
35. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937 [TBL] [Abstract][Full Text] [Related]
36. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635 [TBL] [Abstract][Full Text] [Related]
37. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777 [TBL] [Abstract][Full Text] [Related]
38. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488 [TBL] [Abstract][Full Text] [Related]
39. [Effects of Cordyceps extract on cytokines and transcription factors in peripheral blood mononuclear cells of asthmatic children during remission stage]. Sun W; Yu J; Shi YM; Zhang H; Wang Y; Wu BB Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):341-6. PubMed ID: 20388474 [TBL] [Abstract][Full Text] [Related]
40. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration. Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]